Serum nitrate and NOx levels in preeclampsia are higher than in normal pregnancy

Hypertension in Pregnancy

Volumn 35, Issue 2, 2016, Pages 226-233

  Acauan Filho, Breno José ^a   Pinheiro da Costa, Bartira Ercilia ^a   Ogando, Patrícia Barcelos ^a   Vieira, Matias Costa ^a   Antonello, Ivan Carlos ^a   Poli de Figueiredo, Carlos Eduardo ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Cyclic GMP; endothelium dependent relaxing factors; hypertension; nitrite; pregnancy induced; vasodilatation

Indexed keywords

CREATININE; HEMOGLOBIN; NITRATE; NITRIC OXIDE; URIC ACID; NITRIC ACID DERIVATIVE; NITRITE;

ADULT; APGAR SCORE; ARTERIAL PRESSURE; ARTICLE; BIRTH WEIGHT; BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; FEMALE; GESTATIONAL AGE; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; NITRATE BLOOD LEVEL; NITRIC OXIDE BLOOD LEVEL; PATHOPHYSIOLOGY; PLACENTA WEIGHT; PREECLAMPSIA; PREGNANCY; PRIMIGRAVIDA; SYSTOLIC BLOOD PRESSURE; YOUNG ADULT; ADOLESCENT; BLOOD; BLOOD PRESSURE; PHYSIOLOGY;

ADOLESCENT; ADULT; BLOOD PRESSURE; FEMALE; GESTATIONAL AGE; HUMANS; NITRATES; NITRIC OXIDE; NITRITES; PRE-ECLAMPSIA; PREGNANCY; URIC ACID; YOUNG ADULT;

EID: 84961393664     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.3109/10641955.2016.1139718     Document Type: Article

References (47)

1. E.A.Steegers, P.von Dadelszen, J.J.Duvekot, R.Pijnenborg Pre-eclampsia. Lancet. 2010;376(9741):631–644.
2. C.W.Redman, I.L.Sargent Latest advances in understanding preeclampsia. Science. 2005;308(5728):1592–1594.
3. I.A.Brosens, W.B.Robertson, H.G.Dixon The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu. 1972;1:177–191.
4. Y.Wang, D.F.Lewis, J.S.Alexander, D.N.Granger Endothelial barrier function in preeclampsia. Front Biosci. 2007;12:2412–2424.
5. J.A.Lykke, J.Langhoff-Roos, B.M.Sibai, E.F.Funai, E.W.Triche, M.J.Paidas Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension. 2009;53(6):944–951.
6. S.Moncada, A.Higgs The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329(27):2002–2012.
7. F.Murad Cellular signaling with nitric oxide and cyclic GMP. Braz J Med Biol Res. 1999;32(11):1317–1327.
8. C.Yallampalli, R.E.Garfield Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol. 1993;169(5):1316–1320.
9. M.Vatish, H.S.Randeva, D.K.Grammatopoulos Hormonal regulation of placental nitric oxide and pathogenesis of pre-eclampsia. Trends Mol Med. 2006;12(5):223–233.
10. D.Mao, J.Che, K.Li, et al. Association of homocysteine, asymmetric dimethylarginine, and nitric oxide with preeclampsia. Arch Gynecol Obstet. 2010;282(4):371–375.
11. A.Var, Y.Yildirim, E.Onur, et al. Endothelial dysfunction in preeclampsia. Increased homocysteine and decreased nitric oxide levels. Gynecol Obstet Invest. 2003;56(4):221–224.
12. A.A.Khalil, D.Tsikas, R.Akolekar, J.Jordan, K.H.Nicolaides Asymmetric dimethylarginine, arginine and homoarginine at 11–13 weeks’ gestation and preeclampsia: a case-control study. J Hum Hypertens. 2011.
13. A.H.Shaamash, E.D.Elsnosy, A.M.Makhlouf, M.M.Zakhari, O.A.Ibrahim, H.M.EL-d. Maternal and fetal serum nitric oxide (NO) concentrations in normal pregnancy, pre-eclampsia and eclampsia. Int J Gynaecol Obstet. 2000;68(3):207–214.
14. E.Teran, P.Chedraui, S.Vivero, F.Villena, F.Duchicela, L.Nacevilla Plasma and placental nitric oxide levels in women with and without pre-eclampsia living at different altitudes. Int J Gynaecol Obstet. 2009;104(2):140–142.
15. J.Rowe, S.Campbell, E.D.Gallery Nitric oxide production by decidual endothelial cells is not reduced in preeclampsia. Hypertens Pregn. 2003;22(1):63–75.
16. F.Bernardi, L.Constantino, R.Machado, F.Petronilho, F.Dal-Pizzol Plasma nitric oxide, endothelin-1, arginase and superoxide dismutase in pre-eclamptic women. J Obstet Gynaecol Res. 2008;34(6):957–963.
17. K.Matsubara, Y.Matsubara, S.Hyodo, T.Katayama, M.Ito Role of nitric oxide and reactive oxygen species in the pathogenesis of preeclampsia. J Obstet Gynaecol Res. 2010;36(2):239–247.
18. Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol. 2000;183(1):S1–S22.
19. D.Tsikas Methods of quantitative analysis of the nitric oxide metabolites nitrite and nitrate in human biological fluids. Free Radic Res. 2005;39(8):797–815.
20. L.M.Dusse, B.A.Lwaleed, R.M.Silva, A.J.Cooper, M.G.Carvalho Nitric oxide in pre-eclampsia: be careful with the results! Eur J Obstet Gynecol Reprod Biol. 2008;138(2):242–243.
21. G.D’Aniello, A.Tolino, G.Fisher Plasma L-arginine is markedly reduced in pregnant women affected by preeclampsia. J Chromatogr B Biomed Sci Appl. 2001;753(2):427–431.
22. A.O.Galao, Pinheiro da Costa BE, d’Avila DO, Poli de Figueiredo CE. L-arginine erythrocyte transport increases during pregnancy and immediately postpartum. Am J Obstet Gynecol. 2004;191(2):572–575.
23. B.P.da Costa, J.P.Steibel, I.C.Antonello, J.A.Guimaraes, Poli de Figueiredo CE. L-arginine erythrocyte transport in normal pregnant and preeclamptic women. Am J Obstet Gynecol. 2004;190(2):468–471.
24. A.Pettersson, T.Hedner, I.Milsom Increased circulating concentrations of asymmetric dimethyl arginine (ADMA), an endogenous inhibitor of nitric oxide synthesis, in preeclampsia. Acta Obstet Gynecol Scand. 1998;77(8):808–813.
25. E.Podjarny, S.Ben-Chetrit, M.Rathaus, et al. Pregnancy-induced hypertension in rats with adriamycin nephropathy is associated with an inadequate production of nitric oxide. Hypertension. 1997;29(4):986–991.
26. O.W.Griffith, R.G.Kilbourn Nitric oxide synthase inhibitors: amino acids. Methods Enzymol. 1996;268:375–392.
27. V.C.Sandrim, A.C.Palei, I.F.Metzger, V.A.Gomes, R.C.Cavalli, J.E.Tanus-Santos Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble fms-like tyrosine kinase-1 and soluble endogline in preeclampsia. Hypertension. 2008;52(2):402–407.
28. A.P.Shaik, A.Sultana, V.K.Bammidi, K.Sampathirao, K.Jamil A meta-analysis of eNOS and ACE gene polymorphisms and risk of pre-eclampsia in women. J Obstet Gynaecol. 2011;31(7):603–607.
29. H.Chen, G.Zhao, M.Sun, et al. Endothelial nitric oxide synthase gene polymorphisms (G894T, 4b/a and T-786C) and preeclampsia: meta-analysis of 18 case-control studies. DNA Cell Biol. 2011.
30. F.Schneider, P.Lutun, J.J.Baldauf, et al. Plasma cyclic GMP concentrations and their relationship with changes of blood pressure levels in pre-eclampsia. Acta Obstet Gynecol Scand. 1996;75(1):40–44.
31. B.A.Clark, J.Ludmir, F.H.Epstein, et al. Urinary cyclic GMP, endothelin, and prostaglandin E2 in normal pregnancy and preeclampsia. Am J Perinatol. 1997;14(9):559–562.
32. B.Baksu, I.Davas, A.Baksu, A.Akyol, G.Gulbaba Plasma nitric oxide, endothelin-1 and urinary nitric oxide and cyclic guanosine monophosphate levels in hypertensive pregnant women. Int J Gynaecol Obstet. 2005;90(2):112–117.
33. B.E.Pinheiro da Costa, C.Scocco, C.E.Poli de Figueiredo, G.JAGuimaraes. Increased serum phosphodiesterase activity in women with pre-eclampsia. BJOG. 2006;113(5):577–579.
34. M.Wareing, I.P.Crocker, A.Y.Warren, M.J.Taggart, P.N.Baker Characterization of small arteries isolated from the human placental chorionic plate. Placenta. 2002;23(5):400–409.
35. S.V.Ramesar, I.Mackraj, P.Gathiram, J.Moodley Sildenafil citrate improves fetal outcomes in pregnant, L-NAME treated, Sprague-Dawley rats. Eur J Obstet Gynecol Reprod Biol. 2010;149(1):22–26.
36. N.H.Turgut, T.K.Temiz, I.Bagcivan, B.Turgut, S.Gulturk, B.Karadas The effect of sildenafil on the altered thoracic aorta smooth muscle responses in rat pre-eclampsia model. Eur J Pharmacol. 2008;589(1–3):180–187.
37. R.A.Samangaya, G.Mires, A.Shennan, et al. A randomised, double-blinded, placebo-controlled study of the phosphodiesterase type 5 inhibitor sildenafil for the treatment of preeclampsia. Hypertens Pregn. 2009;28(4):369–382.
38. M.Wareing, J.E.Myers, M.O’Hara, et al. Effects of a phosphodiesterase-5 (PDE5) inhibitor on endothelium-dependent relaxation of myometrial small arteries. Am J Obstet Gynecol. 2004;190(5):1283–1290.
39. M.Wareing, J.E.Myers, M.O’Hara, P.N.Baker Sildenafil citrate (Viagra) enhances vasodilatation in fetal growth restriction. J Clin Endocrinol Metab. 2005;90(5):2550–2555.
40. C.W.Redman, I.L.Sargent Pre-eclampsia, the placenta and the maternal systemic inflammatory response – a review. Placenta. 2003;24(Suppl A):S21–S27.
41. M.Noris, M.Todeschini, P.Cassis, et al. L-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant species. Hypertension. 2004;43(3):614–622.
42. H.D.Mistry, L.O.Kurlak, P.J.Williams, M.M.Ramsay, M.E.Symonds, F.Broughton Pipkin Differential expression and distribution of placental glutathione peroxidases 1, 3 and 4 in normal and preeclamptic pregnancy. Placenta. 2010;31(5):401–408.
43. P.Crosswhite, Z.Sun Nitric oxide, oxidative stress and inflammation in pulmonary arterial hypertension. J Hypertens. 2010;28(2):201–212.
44. J.S.Beckman, W.H.Koppenol Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol. 1996;271(5 Pt. 1):C1424–C1437.
45. N.H.Morris, B.M.Eaton, G.Dekker Nitric oxide, the endothelium, pregnancy and pre-eclampsia. Br J Obstet Gynaecol. 1996;103(1):4–15.
46. F.Vadillo-Ortega, O.Perichart-Perera, S.Espino, et al. Effect of supplementation during pregnancy with L-arginine and antioxidant vitamins in medical food on pre-eclampsia in high risk population: randomised controlled trial. BMJ. 2011;342:d2901.
47. I.Neri, F.Monari, L.Sgarbi, A.Berardi, G.Masellis, F.Facchinetti L-arginine supplementation in women with chronic hypertension: impact on blood pressure and maternal and neonatal complications. J Matern Fetal Neona. 2010;23(12):1456–1460.